Antibody Discovery in Transgenic Animals
Provided by GENOVAC

Transgenic therapeutics to fit your needs 

GENOVAC is the leader in the use of transgenic animal platforms for the generation of fully human, monoclonal antibodies and can assist you in accelerating the development of therapeutic antibodies. The company offers several options for your projects.

OmniDeep® Antibody Discovery

GENOVAC combines its Antibody Technology with Ligand’s OmniAb™ transgenic rodents for superior human antibody development.

Learn More

Trianni Antibody Discovery

Using Trianni Mouse™ with GENOVAC technology allows for efficient generation of fully-human monoclonal antibodies.

Learn More